2019 annual financial data
NovoCure 2019 Operating margin
NovoCure 2019 operating margin with verified reported values.
Direct answer
Operating margin was -0.26%.
Operating income was -914,000 USD and net income was -7,230,000 USD.
Operating cash flow was 26,620,000 USD.
Get free NovoCure email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 351,318,000 USD
- Operating income
- -914,000 USD
- Net income
- -7,230,000 USD
- Operating cash flow
- 26,620,000 USD